Veterinary Infectious Diseases Therapeutics Market Analysis and Forecast 2024-2031

The global veterinary infectious diseases therapeutics market is expected to grow at a significant CAGR during the forecast period. Microorganisms, such as bacteria and viruses, are tiny living entities that can be found everywhere. Only a few of the hundreds of microbe species invading, multiplying, and causing sickness in animals and humans. Most germs dwell on the skin, in the mouth, upper airways, and intestines without causing disease, however, depending on the nature of the microorganism and the level of the pet's natural defenses, certain microbes live in or on a pet, or invade and cause disease.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/veterinary-infectious-diseases-therapeutics-market

According to the World Small Animal Veterinary Association (WSAVA), zoonotic diseases account for 60% to 80% of new diseases, emphasizing the necessity of veterinarians in the detection, prevention, and control of infectious diseases. Rift Valley Fever, is an endemic zoonotic disease that costs farmers $427 million each year in Africa and the Middle East. The primary driving drivers in the veterinary infectious disease therapeutics market are the rising prevalence of infectious disease and the rising demand for dairy, meat, and poultry products.

Antibiotics are commonly used to treat infectious disorders caused by bacteria and other germs in veterinary medicine. Antibiotics such as penicillins, cephalosporins, cephamycins, aminoglycosides, and others are available for the treatment of infectious infections in animals. Infectious diseases caused by infections, germs, and parasites that transfer between animals and humans are known as zoonotic diseases. According to the Centers for Disease Control and Prevention, zoonotic infections resulted in 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 fatalities in 2017. As a result, the market is predicted to rise owing to the rising number of zoonotic diseases, rising pet ownership, and increased research and development (R&D) efforts in veterinary treatments.

Global Veterinary Infectious Diseases Therapeutics Market Report Segmentation

By Product Type

• Antibiotics
• Antiviral
• Antifungal
• Amebicides
• Others

By Animal

• Dogs and Cats
• Horses
• Swine
• Poultry
• Other

A full report of Veterinary Infectious Diseases Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/veterinary-infectious-diseases-therapeutics-market

Veterinary Infectious Diseases Therapeutics Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Elanco Animal Health Inc.
• Zoetis Inc.
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.